Products and Services
-
Nebulizer maker Aerogen and inhaled interferon developer Synairgen have entered a strategic partnership for development of a custom device for delivery of Synairgen’s SNG001 inhaled interferon-beta, the companies have announced, noting that the new agreement… Read more . . .
-
Orbia has announced the delivery of 17 tonnes of Koura Global’s Zephex 152a (HFA-152a), an LGWP propellant, to Kindeva Drug Delivery‘s facility in Loughborough, UK where the CDMO has MDI manufacturing lines for LGWP propellants. Kindeva… Read more . . .
-
German CDMO LTS Lohmann has announced that it will acquire US-based CDMO Renaissance Lakewood, which specializes in injectables and nasal sprays. According to the announcement, Renaissance currently employs approximately 500 employees. LTS currently offers services for… Read more . . .
-
Blow Fill Seal specialist Ritedose, which offers CDMO services and produces its own inhalation solutions, has announced that it will spend $17 million to add 10,000 sq ft of laboratory space, tripling its current lab… Read more . . .
-
Neumifil antiviral nasal spray developer Pneumagen has announced the launch of a platform called NeumoBind for intranasal protein formulations. The company says, “By anchoring proteins in place on a mucosal surface, NeumoBind addresses a critical… Read more . . .
-
Inhaled mRNA developer Ethris and CDMO Evonik have announced a new partnership for development and commercialization of a lipid nanoparticle (LNP) platform for delivery of nucleic acid. Ethris’s SNaP LNP technology will become available to… Read more . . .
-
Strides Pharma Science announced a new development agreement between Strides Pharma Global and OINDP specialist CDMO Kenox Pharmaceuticals for “multiple nasal spray products for the US market across diverse therapeutic indications.” The company did not… Read more . . .
-
Copley Scientific has announced the launch of its new Inhalytix+ subscription-based cascade impactor software package. The original Inhalytix software was introduced in 2021. According to the company, the new software can be integrated with testing equipment… Read more . . .
-
Rocket Science Health, which recently partnered with Kindeva on development of its nasal delivery device, announced that the US Patent and Trademark Office (USPTO) has issued the company US Patent No. 12,343,489, titled, “Intranasal and… Read more . . .
-
HCmed Innovations announced that the FDA has granted 510(k) clearance to the company’s AdheResp connected breath-actuated mesh nebulizer, which delivers aerosol during inhalation only. According to the company, AdheResp is the first nebulizer of its… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden